Payment overview · 2025
General Payments
$30,906.67
147 reported records · 29 companies
Healthcare provider profile · identity verified
Sammy Daniel, David Eghbalieh, M.D.
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · SHERMAN OAKS, CA · NPI 1275794224
Verified facts
What the public records show
CMS Open Payments records show Sammy Daniel, David Eghbalieh, M.D. received $30,906.67 in general payments during 2025 across 147 reported records.
Medtronic, Inc. accounted for 32.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 54 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$9,997.98 | 32.4% | 24 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $4,784.14 | 15.5% | 6 | 2025 |
| Siemens Medical Solutions USA, Inc. | Unresolved — no canonical attribution shown | $4,232.30 | 13.7% | 13 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $3,403.81 | 11.0% | 31 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $1,538.04 | 5.0% | 9 | 2025 |
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $1,514.40 | 4.9% | 2 | 2025 |
| Balt USA, LLC | Unresolved — no canonical attribution shown | $991.74 | 3.2% | 8 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $853.61 | 2.8% | 6 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $672.36 | 2.2% | 7 | 2025 |
| Sirtex Medical Inc | Unresolved — no canonical attribution shown | $589.93 | 1.9% | 3 | 2025 |
| LeMaitre Vascular, Inc. | Unresolved — no canonical attribution shown | $342.66 | 1.1% | 3 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $297.91 | 1.0% | 7 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $288.92 | 0.9% | 2 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $215.33 | 0.7% | 6 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $207.18 | 0.7% | 2 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $173.02 | 0.6% | 1 | 2025 |
| CVRx, Inc. | Unresolved — no canonical attribution shown | $138.62 | 0.5% | 1 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $133.52 | 0.4% | 1 | 2025 |
| Shape Memory Medical Inc. | Unresolved — no canonical attribution shown | $110.42 | 0.4% | 1 | 2025 |
| Koya Medical, Inc. | Unresolved — no canonical attribution shown | $85.78 | 0.3% | 2 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $73.23 | 0.2% | 2 | 2025 |
| Integra LifeSciences Corporation | Unresolved — no canonical attribution shown | $53.11 | 0.2% | 2 | 2025 |
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $40.26 | 0.1% | 2 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $38.15 | 0.1% | 1 | 2025 |
| PolyNovo North America LLC | Unresolved — no canonical attribution shown | $35.89 | 0.1% | 1 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $30.90 | 0.1% | 1 | 2025 |
| MIMEDX Group, Inc. | Unresolved — no canonical attribution shown | $26.27 | 0.1% | 1 | 2025 |
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $19.32 | 0.1% | 1 | 2025 |
| BSN Medical Inc | Unresolved — no canonical attribution shown | $17.87 | 0.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,315.00 | 5 |
| Food and Beverage | $10,430.95 | 127 |
| Travel and Lodging | $6,160.72 | 15 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $9,666.48 | 18 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $4,784.14 | 6 | 2025 |
Source payment records
|
|||||
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $1,917.16 | 7 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $1,538.04 | 9 | 2025 |
Source payment records
|
|||||
| EXCELSIUS GPS Normalized: excelsius gps |
Device | Globus Medical, Inc. | $1,514.40 | 2 | 2025 |
Source payment records
|
|||||
| Prestige Coil System Normalized: prestige coil system |
Device | Balt USA, LLC | $967.41 | 7 | 2025 |
Source payment records
|
|||||
| Cios Alpha Normalized: cios alpha |
Device | Siemens Medical Solutions USA, Inc. | $858.00 | 5 | 2025 |
Source payment records
|
|||||
| Cios Spin Normalized: cios spin |
Device | Siemens Medical Solutions USA, Inc. | $824.37 | 2 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $672.36 | 7 | 2025 |
Source payment records
|
|||||
| General - Vascular Intervention Normalized: general vascular intervention |
Device | Boston Scientific Corporation | $516.44 | 6 | 2025 |
Source payment records
|
|||||
| LAVA LES (Liquid Embolic System) Normalized: lava les liquid embolic system |
Device | Sirtex Medical Inc | $440.87 | 2 | 2025 |
Source payment records
|
|||||
| HYDRO LEMAITRE VALVULOTOME Normalized: hydro lemaitre valvulotome |
Device | LeMaitre Vascular, Inc. | $342.66 | 3 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $341.70 | 3 | 2025 |
Source payment records
|
|||||
| VALIANT CAPTIVIA Normalized: valiant captivia |
Device | Medtronic, Inc. | $312.77 | 5 | 2025 |
Source payment records
|
|||||
| LUTONIX Drug Coated Balloon Normalized: lutonix drug coated balloon |
Device | Bard Peripheral Vascular, Inc., Becton, Dickinson and Company | $278.32 | 2 | 2025 |
Source payment records
|
|||||
| AVVIGO Guidance System Normalized: avvigo guidance system |
Device | Boston Scientific Corporation | $276.79 | 5 | 2025 |
Source payment records
|
|||||
| ROTAPRO Normalized: rotapro |
Device | Boston Scientific Corporation | $229.43 | 7 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $194.44 | 2 | 2025 |
Source payment records
|
|||||
| GORE TAG Conformable Thoracic Stent Graft Normalized: gore tag conformable thoracic stent graft |
Device | W. L. Gore & Associates, Inc. | $191.29 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH ALPHA Normalized: zenith alpha |
Device | Cook Medical LLC | $185.22 | 3 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $181.41 | 1 | 2025 |
Source payment records
|
|||||
| GORE TAG Thoracic Branch Endoprosthesis Normalized: gore tag thoracic branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $181.13 | 1 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $173.02 | 1 | 2025 |
Source payment records
|
|||||
| ENHANCE Transcarotid Peripheral Access Kit Normalized: enhance transcarotid peripheral access kit |
Device | Boston Scientific Corporation | $154.17 | 1 | 2025 |
Source payment records
|
|||||
| SIR-Spheres Microspheres Normalized: sir spheres microspheres |
Device | Sirtex Medical Inc | $149.06 | 1 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc. | $144.12 | 1 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $142.59 | 3 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Normalized: gore excluder thoracoabdominal branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $139.49 | 1 | 2025 |
Source payment records
|
|||||
| NAEOTOM Alpha Normalized: naeotom alpha |
Device | Siemens Medical Solutions USA, Inc. | $139.26 | 1 | 2025 |
Source payment records
|
|||||
| Barostim Neo System Normalized: barostim neo system |
Device | CVRx, Inc. | $138.62 | 1 | 2025 |
Source payment records
|
|||||
| IMPEDE EMBOLIZATION PLUG Normalized: impede embolization plug |
Device | Shape Memory Medical Inc. | $110.42 | 1 | 2025 |
Source payment records
|
|||||
| DAYSPRING Normalized: dayspring |
Device | Koya Medical, Inc. | $85.78 | 2 | 2025 |
Source payment records
|
|||||
| KOYA MEDICAL Normalized: koya medical |
Device | Koya Medical, Inc. | $85.78 | 2 | 2025 |
Source payment records
|
|||||
| SONOPET IQ Normalized: sonopet iq |
Device | Stryker Corporation | $72.74 | 3 | 2025 |
Source payment records
|
|||||
| Varithena Administration Pack Normalized: varithena administration pack |
Device | Boston Scientific Corporation | $61.93 | 1 | 2025 |
Source payment records
|
|||||
| Integra Normalized: integra |
Device | Integra LifeSciences Corporation | $53.11 | 2 | 2025 |
Source payment records
|
|||||
| Integra Dermal Regeneration Template Normalized: integra dermal regeneration template |
Device | Integra LifeSciences Corporation | $53.11 | 2 | 2025 |
Source payment records
|
|||||
| PRIMATRIX Normalized: primatrix |
Device | Integra LifeSciences Corporation | $53.11 | 2 | 2025 |
Source payment records
|
|||||
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $40.26 | 2 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $40.26 | 2 | 2025 |
Source payment records
|
|||||
| STRAVIX Normalized: stravix |
Biological | Smith+Nephew, Inc. | $38.15 | 1 | 2025 |
Source payment records
|
|||||
| NOVOSORB BTM Normalized: novosorb btm |
Device | PolyNovo North America LLC | $35.89 | 1 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $30.90 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER 635 Normalized: zilver 635 |
Device | Cook Medical LLC | $28.84 | 1 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Stent Normalized: enroute transcarotid stent |
Device | Boston Scientific Corporation | $27.03 | 1 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $26.42 | 1 | 2025 |
Source payment records
|
|||||
| PERCLOSE PROSTYLE Normalized: perclose prostyle |
Device | Abbott Laboratories | $25.77 | 1 | 2025 |
Source payment records
|
|||||
| Revere Hybrid Access Catheter Normalized: revere hybrid access catheter |
Device | Balt USA, LLC | $24.33 | 1 | 2025 |
Source payment records
|
|||||
| VIA MATRIX Normalized: via matrix |
Medical Supply | Organogenesis Inc. | $19.32 | 1 | 2025 |
Source payment records
|
|||||
| LIGASURE Normalized: ligasure |
Device | Medtronic, Inc. | $18.73 | 1 | 2025 |
Source payment records
|
|||||
| JOBST SPORT Normalized: jobst sport |
Device | BSN Medical Inc | $17.87 | 1 | 2025 |
Source payment records
|
|||||
| ACUSON Sequoia Diagnostic Ultrasound System Normalized: acuson sequoia diagnostic ultrasound system |
Device | Siemens Medical Solutions USA, Inc. | $8.76 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH Normalized: zenith |
Device | Cook Medical LLC | $8.58 | 1 | 2025 |
Source payment records
|
|||||
| COOK Normalized: cook |
Device | Cook Medical LLC | $5.50 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $30,906.67 · 147 records | Medtronic, Inc. | ACUSON Sequoia Diagnostic Ultrasound System, ARTIX MT, AVVIGO Guidance System, AZUR CX DETACHABLE, Barostim Neo System, CGuard Prime Carotid Stent System, COOK, Cios Alpha, Cios Spin, DAYSPRING, ELUVIA, ENDURANT IIS, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent, ESPRIT, EXCELSIUS GPS, Flexitouch Plus, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE TAG Conformable Thoracic Stent Graft, GORE TAG Thoracic Branch Endoprosthesis, GORE VIABAHN VBX Balloon Expandable Endo, General - Therapies, General - Vascular Intervention, HYDRO LEMAITRE VALVULOTOME, IMPEDE EMBOLIZATION PLUG, Indigo System, Integra, Integra Dermal Regeneration Template, JOBST SPORT, KOYA MEDICAL, LAVA LES (Liquid Embolic System), LIGASURE, LUTONIX Drug Coated Balloon, NAEOTOM Alpha, NOVOSORB BTM, Nimbl, PERCLOSE PROSTYLE, PRIMATRIX, Prestige Coil System, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, ROTAPRO, Revere Hybrid Access Catheter, RotarexS 6 F x 135 cm, SIR-Spheres Microspheres, SONOPET IQ, STRAVIX, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, VALIANT CAPTIVIA, VIA MATRIX, Varithena Administration Pack, ZENITH, ZENITH ALPHA, ZILVER 635 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error